New guidelines issued for arthritis drugsBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7307.251/a (Published 04 August 2001) Cite this as: BMJ 2001;323:251
- Helen Barratt
Patients with osteoarthritis or rheumatoid arthritis who are at high risk of gastrointestinal complications should have access to COX 2 (cyclo-oxygenase-2) selective inhibitors, according to new guidelines from the National Institute for Clinical Excellence.
The institute's long awaited report, which applies to patients in England and Wales, classified high risk patients as those …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial